Related Experiment Video
Updated: Oct 10, 2025

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
Extramedullary plasmacytoma of the nasal inferior turbinate: a case report
Yan Liu1, Xiaopei Yuan1, Xiaohong Peng2
1Department of Otorhinolaryngology, Head and Neck Surgery, Peking University People's Hospital, Beijing, China.
Abstract:
An extramedullary plasmacytoma (EMP) is a rare neoplasm characterized by monoclonal proliferation of plasma cells without features of multiple myeloma. Most EMPs occur in the head and neck region, especially in the aerodigestive tract. We herein report a case of an EMP arising from the nasal inferior turbinate. The mass was surgically removed, and a short cycle of radiotherapy was performed after the surgery. There was no recurrence of the tumor after 1 year of follow-up. These result may be useful for physicians who encounter similar situations in clinical practice.
Insights
Extramedullary plasmacytoma (EMP) is a rare plasma cell neoplasm. This case report details successful surgical removal and radiotherapy for an EMP of the nasal inferior turbinate, with no recurrence after one year.
Area of Science:
- Oncology
- Pathology
Background:
- Extramedullary plasmacytoma (EMP) is a rare plasma cell neoplasm distinct from multiple myeloma.
- EMPs predominantly affect the head and neck, particularly the aerodigestive tract.
Observation:
- A rare case of EMP originating from the nasal inferior turbinate is presented.
- The tumor presented as a localized mass in the nasal cavity.
Findings:
- Surgical excision was the primary treatment modality.
- A short course of postoperative radiotherapy was administered.
- The patient remained disease-free with no recurrence at the 1-year follow-up mark.
Implications:
- This case highlights the successful management of nasal inferior turbinate EMP.
- The findings support a combined surgical and radiotherapy approach for similar cases.
- This information can guide clinical practice for physicians managing rare head and neck neoplasms.

